Saptalis Pharmaceuticals, LLC Email Format

Pharmaceutical ManufacturingNew York, United States11-50 Employees

Saptalis Pharmaceuticals, LLC is a U.S.-based company in the pharmaceutical manufacturing sector that develops, manufactures, and commercializes specialty prescription products. It operates FDA-approved cGMP laboratories and manufacturing facilities in Hauppauge, New York, capable of producing non-sterile and sterile liquid and semi-solid formulations. 

The company serves the specialty Rx market by bringing precise dosage forms to patients through its development and manufacturing capabilities. In June 2026, Saptalis announced the launch of Chlorpromazine HCl Oral Concentrate in two dosage strengths. It maintains a public presence through its website and employs a relatively small staff.

Sign up for free to view info

Company overview Employee directory